Endevica Bio's lead drug candidate is a peptide therapeutic for treating cachexia due to cancer and other chronic conditions. Phase 1 Clinical trials in the US are underway.
| Website | http://www.endevicabio.com |
| Employees | 15 (15 on RocketReach) |
| Founded | 2009 |
| Address | 1601 S Providence Rd, Columbia, Missouri 65211, US |
| Industry | Biotechnology Research |
| Keywords | Peptide Therapeutics, Therapeutic Peptides, Chronic Disease Treatment, Phase 1 Clinical Trials, Clinical Stage, Drug Development, Novel Therapeutics, Medical Research, Biotechnology, Pharmaceutical Research, Clinical Development, Cancer Research, Biopharmaceutical, Oncology, Health |
| Competitors | Bioneer, BioMarin Pharmaceutical Inc., Axovant Sciences Ltd, Audentes Therapeutics, NantKwest, Sangamo Therapeutics, Inc., Plexxikon Inc., CRISPR Therapeutics, ANAVEON AG, CureVac +46 more (view full list) |
Looking for a particular Endevica Bio employee's phone or email?
Allison Gardner is the Director of Communications of Endevica Bio.
15 people are employed at Endevica Bio.
Endevica Bio is based in Columbia, Missouri.